## Management and Epidemiology of Trachoma ### First-Line Antibiotic Treatment **High-Yield:** Azithromycin is the WHO-recommended first-line agent for active trachoma: - **Dose:** 20 mg/kg as a single oral dose (maximum 1 g) - **Advantage:** Single-dose regimen improves compliance compared to tetracycline eye ointment - **Efficacy:** Superior to tetracycline for both systemic and ocular chlamydial infection **Key Point:** Tetracycline 1% eye ointment (applied twice daily for 6 weeks) was the historical standard but is now reserved for: - Pregnant women (azithromycin safety concerns) - Neonatal prophylaxis - Resource-limited settings without access to oral azithromycin ### WHO Elimination Strategy: The "A" Framework **Mnemonic:** **SAFE** — Surgery, Antibiotics, Facial cleanliness, Environmental improvement 1. **Surgery:** Trichiasis and entropion correction 2. **Antibiotics:** Mass drug administration (MDA) with azithromycin 3. **Facial cleanliness:** Health education to reduce transmission 4. **Environmental improvement:** Water and sanitation ### Mass Drug Administration (MDA) Thresholds **High-Yield:** WHO recommends MDA when: - **TF (active trachoma) prevalence ≥5%** in children aged 1–9 years - **TI (intense inflammation) prevalence ≥1%** in any age group - MDA targets the entire population (not just children) to break transmission chains ### The Critical Error: Timing of Surgical Correction **Clinical Pearl:** Surgery for trichiasis (TT) and entropion (TE) must be performed **ONLY after the active inflammatory phase has resolved**. Performing surgery during active trachoma (TF/TI) is contraindicated because: - Active inflammation impairs wound healing - High risk of surgical failure and recurrence - Inflammation may spontaneously improve with antibiotics alone - Surgery should be deferred until at least 3 months after completing antibiotic therapy **Warning:** Operating during active inflammation is a common pitfall in resource-limited settings and leads to poor outcomes. ### Treatment Algorithm ```mermaid flowchart TD A[Active Trachoma Confirmed]:::outcome --> B[Azithromycin 20 mg/kg<br/>single dose]:::action B --> C[Assess for Trichiasis/Entropion]:::decision C -->|Present| D[Wait 3+ months<br/>for inflammation to resolve]:::action C -->|Absent| E[Facial hygiene education<br/>Environmental improvement]:::action D --> F[Surgical correction<br/>in quiescent phase]:::action E --> G[Follow-up at 3 months]:::action F --> G ``` | Aspect | Active Phase (TF/TI) | Cicatricial Phase (TS/TT/TE) | |--------|----------------------|------------------------------| | **Treatment** | Azithromycin oral | Surgery (after inflammation resolves) | | **Timing of surgery** | Contraindicated | Recommended (3+ months post-antibiotics) | | **Goal** | Cure infection, reduce inflammation | Restore lid mechanics, prevent blindness | **Reasoning:** Option 3 is incorrect because surgical correction of trichiasis and entropion must be deferred until the acute inflammatory phase has resolved. Operating during active trachoma (TF/TI) compromises wound healing and increases surgical failure rates. Surgery is part of the "S" in SAFE but only after "A" (antibiotics) has controlled inflammation.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.